Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Observational × Arthritis, Rheumatoid × Certolizumab Pegol × Clear all

Status

Sponsor Class

Study Type

Observational 2 Interventional 2

Sponsor

Conditions

Arthritis, Rheumatoid 2

Interventions

Etanercept 6 Adalimumab 6 Infliximab 5 tocilizumab 3 golimumab 3 tofacitinib 2 Tumor Necrosis Factor Inhibitors 2 Rituximab 2 Certolizumab Pegol 2 Surveys and Questionnaires 1 Standard of Care 1 Practice Guidelines as Topic 1 Phlebotomy 1 Observation 1 Methods 1 Interviews as Topic 1 Educational Status 1 Early Intervention, Educational 1 Dietary Fiber 1 CT-P13 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04798287 2022-06-22

STAR-RA-Cancer

Brigham and Women's Hospital

105,711 enrolled

Arthritis, Rheumatoid

NCT02778789 2019-09-26

Re-Bone

University of Erlangen-Nürnberg Medical School

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon ⚡